Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

307P - Lacrimal gland tumours: Clinical and epidemiological patterns in the United States

Date

23 Nov 2019

Session

Poster display session

Topics

Tumour Site

Head and Neck Cancers

Presenters

Mahmoud KhalafAllah

Citation

Annals of Oncology (2019) 30 (suppl_9): ix97-ix106. 10.1093/annonc/mdz428

Authors

M.T. KhalafAllah1, M.A. Gouda2, A.S. Alfaar3

Author affiliations

  • 1 Clinical Ophthalmology, Faculty of Medicine - Menoufia University, 32721 - Shebin ElKom/EG
  • 2 Clinical Oncology, Faculty of Medicine - Menoufia University, 32721 - Shebin ElKom/EG
  • 3 Neuroscience, Charité - Universitätsmedizin Berlin, 10117 - Berlin/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 307P

Background

Lacrimal gland is an exocrine secretory gland located at the upper temporal fossa of the orbit. It is part of the tear-forming apparatus that constitutes an important orbital structure. However, data available about tumors possibly originating in this site are scarce. In this study, we aimed to spotlight on this rare type of malignancy using the using data from American National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program.

Methods

We used SEER*Stat version 8.3.4, Microsoft Excel, as well as SPSS IBM SPSS Statistics for Windows, Version 21.0. In SEER*Stat, we used the (Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973-2013 varying)) database. We included SEER 18 cases that were diagnosed after 2003 (2004+) in which the primary site was identified as (C69.5 – Lacrimal gland). Only cases with malignant behavior, known age, and those in the Research Database were included.

Results

A total of 491 cases were identified with a median age of 63. Females represented the majority of the analyzed cohort (n = 263, 53.6%). Lacrimal gland tumors were most common among the white race (n = 376, 76.6%). Age-adjusted Incidence rate was 0.6 per 1,000,000 with a median survival of 41 months, while 5-year relative survival was 88.4% (CI: 81.9% - 92.6%). The most common pathology of studied cases was Non-Hodgkin lymphoma (n = 254, 51.7%) (Table).Table:

307P Different pathological subtypes for lacrimal gland tumours

Pathological SubtypeN.%
NHL-Mature B-Cell Lymphomas25451.7 %
Squamous Cell Neoplasms7114.5 %
Adenomas &Adenocarcinomas6413.0 %
Malignant Lymphomas, NOS Or Diffuse326.5 %
Mucoepidermoid Neoplasms173.5 %
Epithelial Neoplasms, NOS102.0 %
Nevi Melanomas81.6 %
Ductal & Lobular Neoplasms71.4 %
Lymphoid Leukemias (C42.1)61.2 %
Transitional Cell Papillomas & Carcinomas40.8 %
Complex Mixed & Stromal Neoplasms40.8 %
Myomatous Neoplasms30.6 %
Basal Cell Neoplasms20.4 %
Complex Epithelial Neoplasms20.4 %
Plasma Cell Tumors20.4 %
Unspecified Neoplasms10.2 %
Cystic, Mucinous & Serous Neoplasms10.2 %
Fibromatous Neoplasms10.2 %
Hodgkin Lymphomas10.2 %
Nhl-Mature T & Nk-Cell Lymphomas10.2 %

Conclusions

Lacrimal gland tumors are extremely rare with incidence rate of 0.6 per million. These tumors are more likely to occur in old age, females, white race. 5-years relative survival is 88.4% with a median survival of 41 months.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.